T13	Treat-Disorder 35 67	refractory multiple myeloma (MM)
T15	Treatment 82 106;149 188	single-agent thalidomide combination with cytotoxic chemotherapy
T17	Effect 210 245	significantly increased risk of DVT
T11	Speculation_cue 234 238	risk
T12	Drug 95 106	thalidomide
T18	Drug 166 175	cytotoxic
T19	Route 176 188	chemotherapy
T16	Adverse_event 192 202	associated
T14	Combination 149 160	combination
E2	Adverse_event:T16 
E1	Combination:T14 arg:T12 arg2:T18